aluates Reports

$ 0.0

Automative

Global Microbiome Therapeutics and Diagnostics Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-23M13715

Global Microbiome Therapeutics and Diagnostics Market Research Report 2023

BUY CHAPTERS

Global Microbiome Therapeutics and Diagnostics Market Research Report 2025

Code: QYRE-Auto-23M13715

Report

July 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

4D Pharma

Capsugel

Gusto Global

MATRISYS BIOSCIENCE

Pierre Fabre

Sunstone Capital

Microbiome Therapeutics and Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Microbiome Therapeutics and Diagnostics Market

The global market for Microbiome Therapeutics and Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics and Diagnostics.

The Microbiome Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microbiome Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Microbiome Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Microbiome Therapeutics and Diagnostics Market Report

Report Metric	Details
Report Name	Microbiome Therapeutics and Diagnostics Market
CAGR	5%
Segment by Type	FMT Microbiome Drugs Others
Segment by Application	Stomach Respiratory Tract Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	4D Pharma, Capsugel, Gusto Global, MatriSys Bioscience, Pierre Fabre, Sunstone Capital
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Therapeutics and Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Microbiome Therapeutics and Diagnostics Market report?

Ans: The main players in the Microbiome Therapeutics and Diagnostics Market are 4D Pharma, Capsugel, Gusto Global, MatriSys Bioscience, Pierre Fabre, Sunstone Capital

What are the Application segmentation covered in the Microbiome Therapeutics and Diagnostics Market report?

Ans: The Applications covered in the Microbiome Therapeutics and Diagnostics Market report are Stomach, Respiratory Tract, Other

What are the Type segmentation covered in the Microbiome Therapeutics and Diagnostics Market report?

Ans: The Types covered in the Microbiome Therapeutics and Diagnostics Market report are FMT, Microbiome Drugs, Others

Recommended Reports

Diagnostics Markets

IVD & Laboratory

Specialty Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 FMT

1.2.3 Microbiome Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Microbiome Therapeutics and Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Stomach

1.3.3 Respiratory Tract

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microbiome Therapeutics and Diagnostics Market Perspective (2020-2031)

2.2 Global Microbiome Therapeutics and Diagnostics Growth Trends by Region

2.2.1 Global Microbiome Therapeutics and Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Microbiome Therapeutics and Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Microbiome Therapeutics and Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Microbiome Therapeutics and Diagnostics Market Dynamics

2.3.1 Microbiome Therapeutics and Diagnostics Industry Trends

2.3.2 Microbiome Therapeutics and Diagnostics Market Drivers

2.3.3 Microbiome Therapeutics and Diagnostics Market Challenges

2.3.4 Microbiome Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microbiome Therapeutics and Diagnostics Players by Revenue

3.1.1 Global Top Microbiome Therapeutics and Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Microbiome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Microbiome Therapeutics and Diagnostics Revenue

3.4 Global Microbiome Therapeutics and Diagnostics Market Concentration Ratio

3.4.1 Global Microbiome Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics and Diagnostics Revenue in 2024

3.5 Global Key Players of Microbiome Therapeutics and Diagnostics Head office and Area Served

3.6 Global Key Players of Microbiome Therapeutics and Diagnostics, Product and Application

3.7 Global Key Players of Microbiome Therapeutics and Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapeutics and Diagnostics Breakdown Data by Type

4.1 Global Microbiome Therapeutics and Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Type (2026-2031)

5 Microbiome Therapeutics and Diagnostics Breakdown Data by Application

5.1 Global Microbiome Therapeutics and Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Microbiome Therapeutics and Diagnostics Market Size (2020-2031)

6.2 North America Microbiome Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025)

6.4 North America Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microbiome Therapeutics and Diagnostics Market Size (2020-2031)

7.2 Europe Microbiome Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025)

7.4 Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Microbiome Therapeutics and Diagnostics Market Size (2020-2031)

9.2 Latin America Microbiome Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 4D Pharma

11.1.1 4D Pharma Company Details

11.1.2 4D Pharma Business Overview

11.1.3 4D Pharma Microbiome Therapeutics and Diagnostics Introduction

11.1.4 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025)

11.1.5 4D Pharma Recent Development

11.2 Capsugel

11.2.1 Capsugel Company Details

11.2.2 Capsugel Business Overview

11.2.3 Capsugel Microbiome Therapeutics and Diagnostics Introduction

11.2.4 Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025)

11.2.5 Capsugel Recent Development

11.3 Gusto Global

11.3.1 Gusto Global Company Details

11.3.2 Gusto Global Business Overview

11.3.3 Gusto Global Microbiome Therapeutics and Diagnostics Introduction

11.3.4 Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025)

11.3.5 Gusto Global Recent Development

11.4 MatriSys Bioscience

11.4.1 MatriSys Bioscience Company Details

11.4.2 MatriSys Bioscience Business Overview

11.4.3 MatriSys Bioscience Microbiome Therapeutics and Diagnostics Introduction

11.4.4 MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025)

11.4.5 MatriSys Bioscience Recent Development

11.5 Pierre Fabre

11.5.1 Pierre Fabre Company Details

11.5.2 Pierre Fabre Business Overview

11.5.3 Pierre Fabre Microbiome Therapeutics and Diagnostics Introduction

11.5.4 Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025)

11.5.5 Pierre Fabre Recent Development

11.6 Sunstone Capital

11.6.1 Sunstone Capital Company Details

11.6.2 Sunstone Capital Business Overview

11.6.3 Sunstone Capital Microbiome Therapeutics and Diagnostics Introduction

11.6.4 Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025)

11.6.5 Sunstone Capital Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

4D Pharma

Capsugel

Gusto Global

MATRISYS BIOSCIENCE

Pierre Fabre

Sunstone Capital

List of Tables

Table 1. Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of FMT

Table 3. Key Players of Microbiome Drugs

Table 4. Key Players of Others

Table 5. Global Microbiome Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Microbiome Therapeutics and Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Microbiome Therapeutics and Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Microbiome Therapeutics and Diagnostics Market Share by Region (2020-2025)

Table 9. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Microbiome Therapeutics and Diagnostics Market Share by Region (2026-2031)

Table 11. Microbiome Therapeutics and Diagnostics Market Trends

Table 12. Microbiome Therapeutics and Diagnostics Market Drivers

Table 13. Microbiome Therapeutics and Diagnostics Market Challenges

Table 14. Microbiome Therapeutics and Diagnostics Market Restraints

Table 15. Global Microbiome Therapeutics and Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Microbiome Therapeutics and Diagnostics Market Share by Players (2020-2025)

Table 17. Global Top Microbiome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2024)

Table 18. Ranking of Global Top Microbiome Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Microbiome Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Microbiome Therapeutics and Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Microbiome Therapeutics and Diagnostics, Product and Application

Table 22. Global Key Players of Microbiome Therapeutics and Diagnostics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Microbiome Therapeutics and Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Type (2020-2025)

Table 26. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Type (2026-2031)

Table 28. Global Microbiome Therapeutics and Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Application (2020-2025)

Table 30. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Application (2026-2031)

Table 32. North America Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 47. 4D Pharma Company Details

Table 48. 4D Pharma Business Overview

Table 49. 4D Pharma Microbiome Therapeutics and Diagnostics Product

Table 50. 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)

Table 51. 4D Pharma Recent Development

Table 52. Capsugel Company Details

Table 53. Capsugel Business Overview

Table 54. Capsugel Microbiome Therapeutics and Diagnostics Product

Table 55. Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)

Table 56. Capsugel Recent Development

Table 57. Gusto Global Company Details

Table 58. Gusto Global Business Overview

Table 59. Gusto Global Microbiome Therapeutics and Diagnostics Product

Table 60. Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)

Table 61. Gusto Global Recent Development

Table 62. MatriSys Bioscience Company Details

Table 63. MatriSys Bioscience Business Overview

Table 64. MatriSys Bioscience Microbiome Therapeutics and Diagnostics Product

Table 65. MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)

Table 66. MatriSys Bioscience Recent Development

Table 67. Pierre Fabre Company Details

Table 68. Pierre Fabre Business Overview

Table 69. Pierre Fabre Microbiome Therapeutics and Diagnostics Product

Table 70. Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)

Table 71. Pierre Fabre Recent Development

Table 72. Sunstone Capital Company Details

Table 73. Sunstone Capital Business Overview

Table 74. Sunstone Capital Microbiome Therapeutics and Diagnostics Product

Table 75. Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Sunstone Capital Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Microbiome Therapeutics and Diagnostics Picture

Figure 2. Global Microbiome Therapeutics and Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Microbiome Therapeutics and Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. FMT Features

Figure 5. Microbiome Drugs Features

Figure 6. Others Features

Figure 7. Global Microbiome Therapeutics and Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Microbiome Therapeutics and Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. Stomach Case Studies

Figure 10. Respiratory Tract Case Studies

Figure 11. Other Case Studies

Figure 12. Microbiome Therapeutics and Diagnostics Report Years Considered

Figure 13. Global Microbiome Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Microbiome Therapeutics and Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Microbiome Therapeutics and Diagnostics Market Share by Region: 2024 VS 2031

Figure 16. Global Microbiome Therapeutics and Diagnostics Market Share by Players in 2024

Figure 17. Global Top Microbiome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Microbiome Therapeutics and Diagnostics Revenue in 2024

Figure 19. North America Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Microbiome Therapeutics and Diagnostics Market Share by Country (2020-2031)

Figure 21. United States Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Microbiome Therapeutics and Diagnostics Market Share by Country (2020-2031)

Figure 25. Germany Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Share by Region (2020-2031)

Figure 33. China Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Microbiome Therapeutics and Diagnostics Market Share by Country (2020-2031)

Figure 41. Mexico Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Share by Country (2020-2031)

Figure 45. Turkey Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2020-2025)

Figure 49. Capsugel Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2020-2025)

Figure 50. Gusto Global Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2020-2025)

Figure 51. MatriSys Bioscience Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2020-2025)

Figure 52. Pierre Fabre Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2020-2025)

Figure 53. Sunstone Capital Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical Microbiology Testing Market Research Report 2025

Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Laboratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vitro Diagnostics Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotic Resistance Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Diagnostics Kits Market Insights Forecast to 2030

Integrated Diagnostic System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

In Vitro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Invasive Fungal Infection Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions